Silent endometriosis is difficult to diagnose since symptoms such as pelvic pain or discomfort are often absent. Routine exams and imaging may not detect the condition, so physicians perform lab tests or tissue analysis to look for associated markers. These tests check for BCL6 and other related markers, which assist physicians in determining the next steps in care. Here’s how doctors test for silent endometriosis:
Scheduling BCL6 Assessments
Physicians evaluate the presence of silent or asymptomatic endometriosis by measuring levels of the BCL6 protein in the uterine lining. BCL6 is a protein associated with abnormal uterine inflammation, which can correlate with endometriosis. Testing for BCL6 provides insight even when patients do not have obvious symptoms of the condition, such as pelvic pain or irregular cycles.
Accurate assessment depends on timing the biopsy carefully within the menstrual cycle. The endometrial lining changes throughout the cycle, and BCL6 expression will fluctuate depending on these hormonal variations. For this reason, clinicians typically schedule the biopsy a few days after ovulation; this is when the endometrium is most receptive and protein levels are most representative of uterine health.
Before the procedure, physicians discuss menstrual cycle tracking and scheduling with patients to make sure the sample is collected at the appropriate time. Coordinating the biopsy with the patient’s cycle helps improve the reliability of the BCL6 measurement. Once the sample is obtained, laboratory analysis can determine whether BCL6 is elevated, which may suggest uterine inflammation consistent with endometriosis. This information then guides further evaluation or management.
Collecting Endometrial Tissue
During a routine office visit, a trained women’s healthcare specialist performs an endometrial biopsy. A biopsy allows them to collect tissue from the uterine lining for an evaluation of silent endometriosis. The procedure involves a thin, flexible catheter inserted through the vagina and cervix into the uterus. Gentle suction is then used to collect a small sample of endometrial cells. This method is a standard, minimally invasive technique for obtaining endometrial tissue and can be performed safely in an office setting.
Once the tissue is collected, it is placed in a preservative solution and sent to a laboratory for analysis. If the sample appears insufficient, the clinician may repeat the collection to make sure enough tissue is available for accurate testing. After the procedure, patients usually take a brief rest and are able to resume normal activities shortly afterward, reflecting the procedure’s low invasiveness.
Preparing the Sample
Once the endometrial tissue arrives at the laboratory, trained technicians analyze it for the protein marker BCL6. This marker has been linked to abnormal uterine inflammation and may be associated with silent endometriosis. The analysis typically uses immunohistochemistry, a technique that detects and measures BCL6 within the tissue. Pathologists review the results to determine whether BCL6 levels are higher than the normal baseline. This information helps clinicians evaluate the potential presence of silent endometriosis and guide further assessment or management.
Reporting Lab Results
After the laboratory measures BCL6 levels in the endometrial tissue, a detailed pathology report is generated and sent to the physician who requested the test. The report includes a summary of BCL6 results, notes any unusual cellular features, and highlights other findings that may be relevant to uterine health. Physicians review these results with the patient during follow-up appointments; they discuss what they mean in the context of overall reproductive health.
A result showing elevated BCL6 suggests a greater likelihood that endometriosis could be present; this prompts further evaluation, such as laparoscopy. A laparoscopy is the standard method for directly visualizing and confirming endometriosis. Results within normal ranges indicate that BCL6 is not elevated above levels typically associated with the condition. Clinicians interpret the BCL6 findings alongside other clinical information, such as symptoms, imaging, and medical history. This information helps them decide on appropriate next steps, whether that involves additional testing or monitoring.
Find Treatment Solutions for Silent Endometriosis
Silent endometriosis can be present even when a person experiences no noticeable symptoms, so diagnosis often requires objective testing beyond standard symptom evaluation. Measuring BCL6 levels through a properly timed endometrial biopsy gives clinicians detailed information about uterine inflammation that may be associated with endometriosis. Accurate testing helps identify cases that might otherwise go undetected. Consult a healthcare provider to determine whether this test is appropriate for you.
Disclaimer
This content is provided for informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical concerns.
Beriful do not guarantee the accuracy or completeness of this information and are not liable for any loss, damage, or consequences resulting from its use.
